These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 30133443)
1. Production and separation of 163Ho for nuclear physics experiments. Heinitz S; Kivel N; Schumann D; Köster U; Balata M; Biasotti M; Ceriale V; De Gerone M; Faverzani M; Ferri E; Gallucci G; Gatti F; Giachero A; Nisi S; Nucciotti A; Orlando A; Pessina G; Puiu A; Ragazzi S PLoS One; 2018; 13(8):e0200910. PubMed ID: 30133443 [TBL] [Abstract][Full Text] [Related]
2. Reactor production and electrochemical purification of (169)Er: a potential step forward for its utilization in in vivo therapeutic applications. Chakravarty R; Chakraborty S; Chirayil V; Dash A Nucl Med Biol; 2014 Feb; 41(2):163-70. PubMed ID: 24480267 [TBL] [Abstract][Full Text] [Related]
3. Production of 166Ho through 164Dy(n, gamma)165Dy(n, gamma)166Dy(beta-)166Ho and separation of 166Ho. Lahiri S; Volkers KJ; Wierczinski B Appl Radiat Isot; 2004 Dec; 61(6):1157-61. PubMed ID: 15388104 [TBL] [Abstract][Full Text] [Related]
4. Neutron-activatable holmium-containing mesoporous silica nanoparticles as a potential radionuclide therapeutic agent for ovarian cancer. Di Pasqua AJ; Yuan H; Chung Y; Kim JK; Huckle JE; Li C; Sadgrove M; Tran TH; Jay M; Lu X J Nucl Med; 2013 Jan; 54(1):111-6. PubMed ID: 23100452 [TBL] [Abstract][Full Text] [Related]
5. Production of GMP-grade radioactive holmium loaded poly(L-lactic acid) microspheres for clinical application. Zielhuis SW; Nijsen JF; de Roos R; Krijger GC; van Rijk PP; Hennink WE; van het Schip AD Int J Pharm; 2006 Mar; 311(1-2):69-74. PubMed ID: 16439073 [TBL] [Abstract][Full Text] [Related]
6. Separation and recovery of exotic radiolanthanides from irradiated tantalum targets for half-life measurements. Chiera NM; Talip Z; Fankhauser A; Schumann D PLoS One; 2020; 15(7):e0235711. PubMed ID: 32645091 [TBL] [Abstract][Full Text] [Related]
7. Palliative care of bone pain due to skeletal metastases: Exploring newer avenues using neutron activated (45)Ca. Chakravarty R; Chakraborty S; Ram R; Nair KV; Rajeswari A; Sarma HD; Dash A Nucl Med Biol; 2016 Feb; 43(2):140-9. PubMed ID: 26872438 [TBL] [Abstract][Full Text] [Related]
8. Searching for Hidden Neutrons with a Reactor Neutrino Experiment: Constraints from the STEREO Experiment. Almazán H; Bernard L; Blanchet A; Bonhomme A; Buck C; Del Amo Sanchez P; El Atmani I; Labit L; Lamblin J; Letourneau A; Lhuillier D; Licciardi M; Lindner M; Materna T; Méplan O; Pessard H; Pignol G; Réal JS; Ricol JS; Roca C; Rogly R; Salagnac T; Sarrazin M; Savu V; Schoppmann S; Soldner T; Stutz A; Vialat M Phys Rev Lett; 2022 Feb; 128(6):061801. PubMed ID: 35213177 [TBL] [Abstract][Full Text] [Related]
9. Bulk production and evaluation of high specific activity Mastren T; Radchenko V; Bach HT; Balkin ER; Birnbaum ER; Brugh M; Engle JW; Gott MD; Guthrie J; Hennkens HM; John KD; Ketring AR; Kuchuk M; Maassen JR; Naranjo CM; Nortier FM; Phelps TE; Jurisson SS; Wilbur DS; Fassbender ME Nucl Med Biol; 2017 Jun; 49():24-29. PubMed ID: 28288384 [TBL] [Abstract][Full Text] [Related]
10. Preparation of neutron-activatable holmium nanoparticles for the treatment of ovarian cancer metastases. Di Pasqua AJ; Huckle JE; Kim JK; Chung Y; Wang AZ; Jay M; Lu X Small; 2012 Apr; 8(7):997-1000. PubMed ID: 22298503 [TBL] [Abstract][Full Text] [Related]
12. Reactor production of promethium-147. Broderick K; Lusk R; Hinderer J; Griswold J; Boll R; Garland M; Heilbronn L; Mirzadeh S Appl Radiat Isot; 2019 Feb; 144():54-63. PubMed ID: 30529496 [TBL] [Abstract][Full Text] [Related]
13. Preparation of Holmium-166 Labelled Macroaggregates for radionuclide synovectomy. Kropácek M; Melichar F; Henková K; Konopková M Nucl Med Rev Cent East Eur; 2003; 6(1):1-4. PubMed ID: 14600925 [TBL] [Abstract][Full Text] [Related]
14. Nuclear data for reactor production of Kulage Z; Cantrell T; Griswold J; Denton D; Garland M; Copping R; Mirzadeh S Appl Radiat Isot; 2021 Jun; 172():109645. PubMed ID: 33689941 [TBL] [Abstract][Full Text] [Related]
15. A new measurement of the half-life of (166m)Ho. Nedjadi Y; Bailat C; Caffari Y; Froidevaux P; Wastiel C; Kivel N; Guenther-Leopold I; Triscone G; Jaquenod F; Bochud F Appl Radiat Isot; 2012 Sep; 70(9):1990-6. PubMed ID: 22421399 [TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of inorganic radioactive holmium-166 microspheres for internal radionuclide therapy. Arranja AG; Hennink WE; Chassagne C; Denkova AG; Nijsen JFW Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110244. PubMed ID: 31753348 [TBL] [Abstract][Full Text] [Related]
17. Neutron-activatable needles for radionuclide therapy of solid tumors. Kim J; Narayan RJ; Lu X; Jay M J Biomed Mater Res A; 2017 Dec; 105(12):3273-3280. PubMed ID: 28804994 [TBL] [Abstract][Full Text] [Related]
19. Radiotherapeutic bandage based on electrospun polyacrylonitrile containing holmium-166 iron garnet nanoparticles for the treatment of skin cancer. Munaweera I; Levesque-Bishop D; Shi Y; Di Pasqua AJ; Balkus KJ ACS Appl Mater Interfaces; 2014 Dec; 6(24):22250-6. PubMed ID: 25396281 [TBL] [Abstract][Full Text] [Related]
20. Fate of Organic Functionalities Conjugated to Theranostic Nanoparticles upon Their Activation. Martinelli J; Denkova AG; Arranja A; Terpstra BE; Zhang W; Djanashvili K Bioconjug Chem; 2016 Feb; 27(2):446-56. PubMed ID: 26619135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]